Signal transduction inhibitor

Signal transduction inhibitors are drugs that block signals passed from one molecule to another inside a cell. Blocking these signals can affect many functions of the cell, including cell division and cell death, and may kill cancer cells and their ability to multiply quickly and invade other tissues.^[1]

References

^ Vlasceanu, George M.; Victor, Lamaru; Maricica, Hodorogea; Raluca, Tudor; Vlad, Ologeanu; Gheorghe, Irina; Bolocan, Alexandra; Grumezescu, Alexandru M.; Holban, Alina M. (2017). "Nanostructures for cancer therapy: From targeting to selective toxicology". Nanostructures for Cancer Therapy. pp. 831–847. doi:10.1016/B978-0-323-46144-3.00030-1. ISBN 978-0-323-46144-3. Signal transduction inhibitors stop the activities of the molecules that assist in signal transduction, a process that ensures that once a cell has received a specific signal, the signal is reset within the cell.

External links

Signal transduction inhibitor entry in the public domain NCI Dictionary of Cancer Terms

This article incorporates public domain material from Dictionary of Cancer Terms. U.S. National Cancer Institute.

This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.

[1] Vlasceanu, George M.; Victor, Lamaru; Maricica, Hodorogea; Raluca, Tudor; Vlad, Ologeanu; Gheorghe, Irina; Bolocan, Alexandra; Grumezescu, Alexandru M.; Holban, Alina M. (2017). "Nanostructures for cancer therapy: From targeting to selective toxicology". Nanostructures for Cancer Therapy. pp. 831–847. doi:10.1016/B978-0-323-46144-3.00030-1. ISBN 978-0-323-46144-3. Signal transduction inhibitors stop the activities of the molecules that assist in signal transduction, a process that ensures that once a cell has received a specific signal, the signal is reset within the cell.

[1]